Microbix Biosystems Inc. T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.

TSX:MBX - Post by User

Microbix Biosystems Inc. > StatCan just dropped a bombshell...

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Dec 08, 2023 5:20pm

114 Views

Post# 35775717

RE:StatCan just dropped a bombshell...

Government policy flipped to 'don't test' for COVID...
Given the increased cumulative risk of long COVID with each infection they may be forced to reevaluate policy. Widespread repeat infection is going to be costly with each new wave.

prophetoffactz wrote:

@lisa_iannattone

StatCan just dropped a bombshell report on LC. This is the most important figure. It highlights that the risk of long term symptoms is cumulative, it increases with increasing number of infections. By 3+ infections, 38% report long term symptoms — that’s 1 in every 2.6 people.